Abstract
The “First International Symposium on Genetic Anticancer Agents,” which took place in Amsterdam on March 8–9, 2000, served as a forum to review the results of preclinical and clinical gene therapy studies for cancer endeavored to date.
Despite the fact that gene therapy was initially conceptualized as an approach for inherited genetic disease, it is currently finding its widest employ for treating neoplastic disorders. In this regard, more than 70% of patients treated to date in human clinical gene therapy protocols have been in the context of anticancer regimens. Of note, the application of gene therapy for cancer has proceeded from the same rational basis as was originally conceptualized for inherited genetic disorders. Specifically, the molecular basis of these disorders is increasingly being understood, therapeutic genes are available, and alternative therapies are often lacking. Most recently, the field of gene therapy has enjoyed the realization of the first incontrovertible evidence of clinical benefit, for hemophilia and cardiovascular disease, in its first 15 years of human application. This recent recognition of the potential power of gene therapy, and the current lack of realizing such ends for neoplastic disease, has led to a reassessment of the field. Such a critical analysis is a necessary step in defining the means to progress the technology toward achieving the potential benefits of gene therapy for cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Curiel, D., Gerritsen, W. & Krul, M. Progress in cancer gene therapy. Cancer Gene Ther 7, 1197–1199 (2000). https://doi.org/10.1038/sj.cgt.7700222
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700222
Keywords
This article is cited by
-
Enhancement of transfection efficiency for HeLa cells via incorporating arginine moiety into chitosan
Chinese Science Bulletin (2007)
-
Suppressor of cytokine signaling-1 expression by infectivity-enhanced adenoviral vector inhibits IL-6-dependent proliferation of multiple myeloma cells
Cancer Gene Therapy (2006)
-
Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression
Gene Therapy (2005)
-
Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes
Cancer Gene Therapy (2004)
-
Bcl-2 and Bcl-xL differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24
Oncogene (2003)